Skip to main content

Year: 2023

Brunel reports continued profitable growth, delays in offshore wind industry

Amsterdam, 3 November 2023 – Brunel International N.V. (Brunel; BRNL), a global provider of flexible workforce solutions and expertise, today announced its third quarter 2023 results. Key points Q3 2023Revenue of EUR 342 million, up 13% (21% organically*) Gross Profit of EUR 73 million, up 11% (19% organically) EBIT of EUR 18.8 million, up 8% (27% organically)Key points YTD 2023Revenue of EUR 986 million, up 14% (19% organically) Gross profit of EUR 207 million, up 11% (16% organically) EBIT of EUR 45.6 million, up 6% (14% organically)Outlook Q4 2023Delays in offshore wind industry impacting Taylor Hopkinson Start of large infrastructure project in Middle East & India postponed until Q1 2024 Positive trend continues in other regionsCapital Markets Day on 28 November 2023 *Organic change is measured by excluding the...

Continue reading

Ayvens reports third quarter and nine months 2023 results

PRESS RELEASE QUARTERLY FINANCIAL INFORMATION Ayvens1 reports third quarter and nine months 2023 results2EARNING ASSETS3 UP 14.1% VS. SEPTEMBER 20224 UNDERPINNED BY THE INCREASE IN VEHICLE VALUE LARGEST GLOBAL MULTI-BRAND EV5 FLEET: 505 THOUSAND AS AT 30 SEPTEMBER 2023 LEASING CONTRACT AND SERVICES MARGINS UP 61.6% IN Q3 2023 VS. Q3 2022 AND STABLE ON A LIKE-FOR-LIKE BASIS6 UCS RESULT PER UNIT7 AT EUR 1,033 IN Q3 2023 AFTER THE IMPACT OF REDUCTION IN DEPRECIATION COSTS8 (VS. EUR 3,014 IN Q3 2022), IN LINE WITH EXPECTATIONS COST TO INCOME RATIO (EXCLUDING UCS RESULT) AT 61.1% VS. 57.0% IN Q3 20226 NET INCOME (GROUP SHARE): EUR 226.2 MILLION9 IN Q3 2023, DOWN 28.9% VS. EXCEEDINGLY HIGH Q3 2022 BASE. IMPACT OF VOLATILITY OF MARK TO MARKET OF HEDGING INSTRUMENTS AND DECREASE IN UCS PROFITS CET 1 RATIO AT 12.3% AS AT END SEPTEMBER 2023Q3...

Continue reading

Interim Report Q3 2023

The Interim Report for the 3rd Quarter 2023 for A.P. Møller – Mærsk A/S is hereby enclosed. CEO of A.P. Møller – Mærsk A/S, Vincent Clerc, states: “Our industry is facing a new normal with subdued demand, prices back in line with historical levels and inflationary pressure on our cost base. Since the summer, we have seen overcapacity across most regions triggering price drops and no noticeable uptick in ship recycling or idling. Given the challenging times ahead, we accelerated several cost and cash containment measures to safeguard our financial performance. While continuously streamlining our organisation and operations, we remain dedicated to our strategy of fulfilling our customers’ diversified supply chain needs while pursuing growth opportunities across our Terminals business and Logistic & Services” Contact persons: Head...

Continue reading

AS Tallink Grupp Statistics for October 2023

In October 2023 AS Tallink Grupp transported 470,702 passengers, which is a 3.6% increase compared to October 2022. The number of cargo units decreased by 17.7% to 27,137 units and the number of passenger vehicles increased by 1.5% to 63,151 units in the same comparison. AS Tallink Grupp passenger, cargo unit and passenger vehicles numbers for October 2023 were the following:  October 2023 October 2022 ChangePassengers 470,702 454,207 3.6%Finland-Sweden 139,020 159,200 -12.7%Estonia-Finland 285,022 252,558 12.9%Estonia-Sweden 46,660 42,449 9.9%       Cargo Units 27,137 32,959 -17.7%Finland-Sweden 3,315 4,251 -22.0%Estonia-Finland 19,589 25,219 -22.3%Estonia-Sweden 4,233 3,489 21.3%       Passenger Vehicles 63,151 62,213 1.5%Finland-Sweden 4,312 5,257 -18.0%Estonia-Finland 57,035 54,922 3.8%Estonia-Sweden 1,804 2,034 -11.3%FINLAND–SWEDENIn...

Continue reading

Mendus Phase 1 vididencel clinical trial results in AML and high-risk MDS patients published in peer-reviewed medical journal

Press Release Stockholm, Sweden, November 3, 2023Mendus Phase 1 vididencel clinical trial results in AML and high-risk MDS patients published in peer-reviewed medical journalPublication provides additional clinical evidence that vididencel has strong potential as a new maintenance therapy in AML and high-risk MDS patients Patients with low disease burden have the best chance to respond to vididencel treatment, supporting the maintenance therapy setting currently pursued in the ADVANCE II Phase 2 trial Patients with adverse cytogenetic risk profile may still respond to vididencel therapy Results also indicate that vididencel can be safely and effectively combined with azacitidineMendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced the publication of...

Continue reading

Solvay 2023 third quarter results

November 3, 2023 at 7 a.m. CEST Solvay 2023 third quarter results Strong cash generation and sustained margins in a weak demand environment   HighlightsNet sales in the third quarter of 2023 were down by -20.3% organically versus a record Q3 2022 as expected due to -15% lower volumes (€-512 million) in a weaker macro environment and -5% lower prices (€-188 million) in a context of lower raw material costs and energy prices. On a sequential basis, net sales were down -11% versus Q2. The volume reduction was broad based across regions and businesses.  Structural cost savings for the first nine months of 2023 amounted to €63 million, bringing the total savings since 2019 to €530 million.   Underlying EBITDA of €702 million in Q3 2023 was down by -18.5% organically compared to a record Q3 2022 driven by lower volumes, partly offset...

Continue reading

Construction contract (Golden Gate office building in Tallinn)

Nordecon AS and Rotermann Pluss OÜ, the owner of the Golden Gate office building being developed by US Real Estate, entered into a contract for the design and construction of the office building in Tallinn, located at Ahtri 6. The gross area of the Golden Gate office building with six above-ground and two underground floors is approx. 19,500 sqm, including 102 parking spaces. Commercial spaces and restaurants with outdoor terraces are planned on the ground floor of the building, Class A office space on the upper floors. Parking has been moved underground and a green terrace is created on the roof of the building. The Golden Gate office building will be built as a near-zero energy building and according to the LEED Gold environmental certificate. The total cost of the contract is 23.5 million euros excluding VAT, and the works will be completed...

Continue reading

ForFarmers N.V.: ForFarmers third quarter 2023 Trading Update

Lochem, 3 November 2023 ForFarmers third quarter 2023 Trading Update “The results in the third quarter show a recovery of underlying EBITDA. Sales volumes did decline compared to last year in the third quarter, but were roughly equal to the second quarter of this year. The new way of working, in which local organisations are active in the market with various products and specific advice, is bearing fruit. It underpins our confidence in the more positive result development for the second half of the year, as stated in our first half-year press release. We received permission to sell the compound feed activities in Belgium and closed this transaction in October. We also hope to be able to close the already announced acquisition of Piast in Poland soon. This strengthens the basis for our further development. Delivering good feed at a competitive...

Continue reading

Societe Generale: Third quarter 2023 earnings

RESULTS AT 30 SEPTEMBER 2023Press releaseParis, 3 November 2023 The results are for the first time published and commented under the reported view, as announced during the Capital Markets Day QUARTERLY RESULTS Quarterly revenues of EUR 6.2 billion, down by -6.2% vs. Q3 22, mainly as a result of the peak of the impact of short-term hedges on the net interest income reached in Q3 23 in French retailCost-to-income ratio at 70.4% in Q3 23, with operating expenses increasing by less than +1% vs. Q3 22, at constant perimeter Low cost of risk at 21 basis points in Q3 23, now on expected to be below 20 basis points for FY 2023 Exceptional net income impact of EUR -610m1 due to the goodwill impairment of the African, Mediterranean basin and Overseas activities and Equipment Finance activities for a total amount of around EUR -340 million, and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.